Replies to post #60132 on Vivos Inc (RDGL)

[West Coast Snapper]

It is a great answer. The FDA is worried about potential damage to surrounding healthy tissue. Since 99.9% of the product stays contained inside the tumor, there is no risk to surrounding healthy tissue. Standard of care for any oncologist factors in some damage to surrounding tissue for traditional treatments. Radiogel outperforms every other brachytherapy treatment for safety by a mile. Thx for the compliment